期刊文献+

尿激酶型纤溶酶原激活物对关节软骨蛋白多糖的影响 被引量:1

The Effect of Urokinase Plasminogen Activator on Proteoglycan in Articular Cartilage Matrix
下载PDF
导出
摘要 观察尿激酶型纤溶酶原激活物(urokinase-type plasminogen activator,uPA)对关节软骨基质中蛋白多糖的影响。实验选择健康新西兰大白兔42只并随机分为实验组和对照组,实验组24只,对照组18只;实验组在右膝关节内注射uPA 0.4μg/0.2mL,对照组注射等容量的生理盐水,注射后在4周、8周、12周分批处死取兔软骨提取测定葡糖氨基聚糖(glycosaminoglycan,GAG)含量。结果显示,在不同时期,GAG的总含量均减少,这些改变随时间的延长而渐不明显。由此可知,尿激酶型纤溶酶原激活物能降解关节软骨蛋白多糖,进而导致关节软骨的破坏。 To observe the changes of proteoglycan(PG) of articular cartilage matrix of using intra-articular urokinase Plasminogen Activator in different stages and to research the uPA relative to cartilage matrix metabolism. The 42 white rabbits were devided into 3 groups and were injected intraarticularly with 0.4ug/0.2mL uPA, control animals were injected with the same dose of normal saline. All animals were killed in 4,8,12 weeks respectively after the injections. Glycosaminoglycan(GAG) was extracted from cartilage and was detected with biochemical techniques. Results show the quantity of total GAG of articular cartilige matrix has significant changes in different stages, but the change gradually diminished by the extension of time. Conclusion : uPA is able to degrade GAG of the articular cartilage matrix, then causes the cartilage destruction of joint.
出处 《石河子大学学报(自然科学版)》 CAS 2005年第4期442-445,共4页 Journal of Shihezi University(Natural Science)
  • 相关文献

参考文献5

  • 1Jolles P.Proteoglycan[M].Berlin:Birkhauser Verlag,1994.
  • 2张唯杰.复合多糖生化研究技术[M].上海:上海科学技术出版社,1987..
  • 3Mankin H J,Dorfman H.Biochemical and metabolic abnormaliaties in articular cartilage from Osteoarthritic human hips[J].J Bone Jt Surg(Am),1971,53:523-537.
  • 4卫晓恩,杨庆铭,邓廉夫,朱颖华.骨关节炎软骨基质蛋白多糖变化的实验研究[J].中华风湿病学杂志,2002,6(1):25-27. 被引量:21
  • 5Trippel S B.Growth factor actions on articular cartilage[J].J Rhematol,1995,43(增刊):129-132.

二级参考文献14

  • 1Jolles P.Proteoglycan.Berlin:Birkhauser Verlag,1994.1、31-32、38、248.
  • 2张唯杰,主编.复合多糖生化研究技术.上海:上海科学技术出版社,1987.63-299.
  • 3Pottenger LA,Webb JE,Lyon NB.Kinetics of extraction of PG from human cartilage.Arthritis Rheum,1985,28:323-330.
  • 4Little CB,Ghosh P,Bellenger CR.Topographic variation in biglycan and clecoriin synthesis by articular cartilage in the early stage of OA:an experimental study in sheep.J Orthop Res,1996,14:433-444.
  • 5Fosang AJ,Last K,Gardiner P,et al.Development of a cleavage site specific monoclonal antibody for detecting metalloproteinase derived aggrecan fragments:detaction of fragments in human synovial fluids.Biochem J,1995,310:337-343.
  • 6Lark MW,Bayne EK,Flanagan J,et al.Aggrecan degradation in human cartilage:evidence for both matrix metalloproteinase and aggrecanase activity in mormal,osteoarthritic,and heumatoid joints.J Clin Invest,1997,100:93-106.
  • 7Lotz M,Blanco FJ,von Kempis J,et al.Cytokine regulation of chondrocyte functions.J Rheumatol,1995,43(Suppl):104-108.
  • 8Trippel SB.Growth factor actions on articular cartilage.J Rheumatol,1995,43(Suppl):129-132.
  • 9Neame PJ,Sandy JD.Cartilage aggrecan:biosynthesis,degradation and osteoarthritis.J Fla Med Assoc,1994,81:191-193.
  • 10Slater RR,Bayliss MT,Lachicwicz PF.Monoclonal antibodies that detect biochemical markers of arthritis in humans.Arthritis Rheum,1995,38:655.

共引文献20

同被引文献19

  • 1刘世清,王海斌,邱波.高脱乙酰度羧甲基壳聚糖对实验性兔膝骨关节炎软骨退行性变的影响[J].中国临床康复,2004,8(26):5567-5569. 被引量:2
  • 2李茂强,史晨辉,李宽新,胡文浩,王永明,刘维钢,董金波,李洪安.骨关节炎滑膜uPA,uPAR,tPA表达及意义[J].中国矫形外科杂志,2004,12(21):1686-1688. 被引量:16
  • 3李宁华.中老年人群骨关节炎的流行病学特征[J].中国临床康复,2005,9(38):133-135. 被引量:196
  • 4Chu SC,Yang SF,Lue KH,et al.Glucosamine sulfate suppresses the expressions of urokinase plasminogen activator and inhibitor and gelatinases during the early stage of osteoarthritis.Clin Chim Acta 2006;372(1-2):167-172.
  • 5Pelletier JP,Mineau F,Faure MP,et al.Imbalance between the mechanisms of activation and inhibition of metalloproteases in the early lesions of experimental osteoarthritis Arthritis Rheum 1990;33(10):1466-1476.
  • 6王维山,史晨辉,周卓浩,王永明,董金波,刘维钢,何斌,管兴发.一侧免膝关节注射外源性尿激酶型纤溶酶原激活物引起双侧膝关节软骨降解的实验[J].中国组织工程研究与临床康复,2007,11(19):3738-3741.[www.zglckf.com/zglckf/ejoumal/upfiles/07-19/19k-3738(ps).pdf].
  • 7Martel-Pelletier J.Pathophysiology of osteoarthritis.Osteoarthritis Cartilage 2004;12 Suppl A:S31-S33.
  • 8Stove J,Gremmes C,Gunther KP,et al.Metabolic activity and gene expression of osteoarthritic chondrocytes in correlation with radiological and histological characteristics.Biomed Pharmacother 2006;23.
  • 9Alfano D,Franco P,Vocca I,et al.The urokinase plasminogen activator and its receptor:role in cell growth and apoptosis.Thromb Haemost 2005;93(2):205-211.
  • 10Hart B,Nakamura M,Moril,et al.Urokinase-type plasminogen activator system and breast cancer(Review).Oncol Rep 2005;14(1):105-112.

引证文献1

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部